Dataset Information

Emergence and spread of two SARS-CoV-2 variants of interest in Nigeria.

ABSTRACT: Identifying the dissemination patterns and impacts of a virus of economic or health importance during a pandemic is crucial, as it informs the public on policies for containment in order to reduce the spread of the virus. In this study, we integrated genomic and travel data to investigate the emergence and spread of the SARS-CoV-2 B.1.1.318 and B.1.525 (Eta) variants of interest in Nigeria and the wider Africa region. By integrating travel data and phylogeographic reconstructions, we find that these two variants that arose during the second wave in Nigeria emerged from within Africa, with the B.1.525 from Nigeria, and then spread to other parts of the world. Data from this study show how regional connectivity of Nigeria drove the spread of these variants of interest to surrounding countries and those connected by air-traffic. Our findings demonstrate the power of genomic analysis when combined with mobility and epidemiological data to identify the drivers of transmission, as bidirectional transmission within and between African nations are grossly underestimated as seen in our import risk index estimates.

SUBMITTER: Olawoye IB

PROVIDER: S-EPMC9924892 | biostudies-literature | 2023 Feb

REPOSITORIES: biostudies-literature

ACCESS DATA

Publications

Emergence and spread of two SARS-CoV-2 variants of interest in Nigeria.

Olawoye Idowu B IB Oluniyi Paul E PE Oguzie Judith U JU Uwanibe Jessica N JN Kayode Tolulope A TA Olumade Testimony J TJ Ajogbasile Fehintola V FV Parker Edyth E Eromon Philomena E PE Abechi Priscilla P Sobajo Tope A TA Ugwu Chinedu A CA George Uwem E UE Ayoade Femi F Akano Kazeem K Oyejide Nicholas E NE Nosamiefan Iguosadolo I Fred-Akintunwa Iyanuoluwa I Adedotun-Sulaiman Kemi K Brimmo Farida B FB Adegboyega Babatunde B BB Philip Courage C Adeleke Richard A RA Chukwu Grace C GC Ahmed Muhammad I MI Ope-Ewe Oludayo O OO Otitoola Shobi G SG Ogunsanya Olusola A OA Saibu Mudasiru F MF Sijuwola Ayotunde E AE Ezekiel Grace O GO John Oluwagboadurami G OG Akin-John Julie O JO Akinlo Oluwasemilogo O OO Fayemi Olanrewaju O OO Ipaye Testimony O TO Nwodo Deborah C DC Omoniyi Abolade E AE Omwanghe Iyobosa B IB Terkuma Christabel A CA Okolie Johnson J Ayo-Ale Olubukola O Ikponmwosa Odia O Benevolence Ebo E Naregose Grace O GO Patience Akhilomen E AE Blessing Osiemi O Micheal Airende A Jacqueline Agbukor A Aiyepada John O JO Ebhodaghe Paulson P Racheal Omiunu O Rita Esumeh E Rosemary Giwa E GE Solomon Ehikhametalor E Anieno Ekanem E Edna Yerumoh Y Chris Aire O AO Donatus Adomeh I AI Ogbaini-Emovon Ephraim E Tatfeng Mirabeau Y MY Omunakwe Hannah E HE Bob-Manuel Mienye M Ahmed Rahaman A RA Onwuamah Chika K CK Shaibu Joseph O JO Okwuraiwe Azuka A Ataga Anthony E AE Bock-Oruma Andrew A Daramola Funmi F Yusuf Ibrahim F IF Fajola Akinwumi A Ntia Nsikak-Abasi NA Ekpo Julie J JJ Moses Anietie E AE Moore-Igwe Beatrice W BW Fakayode Oluwatosin E OE Akinola Monilade M Kida Ibrahim M IM Oderinde Bamidele S BS Wudiri Zara W ZW Adeyemi Oluwapelumi O OO Akanbi Olusola A OA Ahumibe Anthony A Akinpelu Afolabi A Ayansola Oyeronke O Babatunde Olajumoke O Omoare Adesuyi A AA Chukwu Chimaobi C Mba Nwando G NG Omoruyi Ewean C EC Olisa Olasunkanmi O Akande Olatunji K OK Nwafor Ifeanyi E IE Ekeh Matthew A MA Ndoma Erim E Ewah Richard L RL Duruihuoma Rosemary O RO Abu Augustine A Odeh Elizabeth E Onyia Venatius V Ojide Chiedozie K CK Okoro Sylvanus S Igwe Daniel D Ogah Emeka O EO Khan Kamran K Ajayi Nnennaya A NA Ugwu Collins N CN Ukwaja Kingsley N KN Ugwu Ngozi I NI Abejegah Chukwuyem C Adedosu Nelson N Ayodeji Olufemi O Liasu Ahmed A AA Isamotu Rafiu O RO Gadzama Galadima G Petros Brittany A BA Siddle Katherine J KJ Schaffner Stephen F SF Akpede George G Erameh Cyril Oshomah CO Baba Marycelin M MM Oladiji Femi F Audu Rosemary R Ndodo Nnaemeka N Fowotade Adeola A Okogbenin Sylvanus S Okokhere Peter O PO Park Danny J DJ Mcannis Bronwyn L BL Adetifa Ifedayo M IM Ihekweazu Chikwe C Salako Babatunde L BL Tomori Oyewale O Happi Anise N AN Folarin Onikepe A OA Andersen Kristian G KG Sabeti Pardis C PC Happi Christian T CT

Nature communications 20230213 1

Identifying the dissemination patterns and impacts of a virus of economic or health importance during a pandemic is crucial, as it informs the public on policies for containment in order to reduce the spread of the virus. In this study, we integrated genomic and travel data to investigate the emergence and spread of the SARS-CoV-2 B.1.1.318 and B.1.525 (Eta) variants of interest in Nigeria and the wider Africa region. By integrating travel data and phylogeographic reconstructions, we find that t ...[more]

PMID: 36781860

Similar Datasets

Project description:Coronavirus disease 2019 (COVID-19) has emerged in December 2019 when the first case was reported in Wuhan, China and turned into a pandemic with 27 million (September 9th) cases. Currently, there are over 95,000 complete genome sequences of the severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), the virus causing COVID-19, in public databases, accompanying a growing number of studies. Nevertheless, there is still much to learn about the viral population variation when the virus is evolving as it continues to spread. We have analyzed SARS-CoV-2 genomes to identify the most variant sites, as well as the stable, conserved ones in samples collected in the Netherlands until June 2020. We identified the most frequent mutations in different geographies. We also performed a phylogenetic study focused on the Netherlands to detect novel variants emerging in the late stages of the pandemic and forming local clusters. We investigated the S and N proteins on SARS-CoV-2 genomes in the Netherlands and found the most variant and stable sites to guide development of diagnostics assays and vaccines. We observed that while the SARS-CoV-2 genome has accumulated mutations, diverging from reference sequence, the variation landscape is dominated by four mutations globally, suggesting the current reference does not represent the virus samples circulating currently. In addition, we detected novel variants of SARS-CoV-2 almost unique to the Netherlands that form localized clusters and region-specific sub-populations indicating community spread. We explored SARS-CoV-2 variants in the Netherlands until June 2020 within a global context; our results provide insight into the viral population diversity for localized efforts in tracking the transmission of COVID-19, as well as sequenced-based approaches in diagnostics and therapeutics. We emphasize that little diversity is observed globally in recent samples despite the increased number of mutations relative to the established reference sequence. We suggest sequence-based analyses should opt for a consensus representation to adequately cover the genomic variation observed to speed up diagnostics and vaccine design.

Project description:The successive emergence of SARS-CoV-2 mutations has led to an unprecedented increase in COVID-19 incidence worldwide. Currently, vaccination is considered to be the best available solution to control the ongoing COVID-19 pandemic. However, public opposition to vaccination persists in many countries, which can lead to increased COVID-19 caseloads and hence greater opportunities for vaccine-evasive mutant strains to arise. To determine the extent that public opinion regarding vaccination can induce or hamper the emergence of new variants, we develop a model that couples a compartmental disease transmission framework featuring two strains of SARS-CoV-2 with game theoretical dynamics on whether or not to vaccinate. We combine semi-stochastic and deterministic simulations to explore the effect of mutation probability, perceived cost of receiving vaccines, and perceived risks of infection on the emergence and spread of mutant SARS-CoV-2 strains. We find that decreasing the perceived costs of being vaccinated and increasing the perceived risks of infection (that is, decreasing vaccine hesitation) will decrease the possibility of vaccine-resistant mutant strains becoming established by about fourfold for intermediate mutation rates. Conversely, we find increasing vaccine hesitation to cause both higher probability of mutant strains emerging and more wild-type cases after the mutant strain has appeared. We also find that once a new variant has emerged, perceived risk of being infected by the original variant plays a much larger role than perceptions of the new variant in determining future outbreak characteristics. Furthermore, we find that rapid vaccination under non-pharmaceutical interventions is a highly effective strategy for preventing new variant emergence, due to interaction effects between non-pharmaceutical interventions and public support for vaccination. Our findings indicate that policies that combine combating vaccine-related misinformation with non-pharmaceutical interventions (such as reducing social contact) will be the most effective for avoiding the establishment of harmful new variants.

Dataset Information

Emergence and spread of two SARS-CoV-2 variants of interest in Nigeria.

Publications

Emergence and spread of two SARS-CoV-2 variants of interest in Nigeria.

Similar Datasets

OmicsDI is part of the ELIXIR infrastructure

Tweets